Rezolute, Inc. Common Stock (NV) (RZLT) Stock
NASDAQ · RZLT
3.91
Fundamentals
Market cap
$369.76M
Price / Earnings ratio
-4.5x
Price / Sales ratio
N/A
Price / Book ratio
3.2x
Return on assets
-0.6%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Rezolute, Inc. Common Stock (NV)
No description available.
SectorHealthcare
IndustryBiotechnology
Employees68
CEOMr. Nevan Charles Elam J.D.
IPO DateMay 1, 2014
HeadquartersRedwood City, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Nevan Charles Elam J.D. | Founder, CEO, Principal Financial Officer & Acting Chairman of the Board | 1967 |
| Mr. Daron G. Evans M.B.A., M.S. | Chief Financial & Business Officer | 1974 |
| Dr. Brian Kenneth Roberts M.D. | Chief Medical Officer | 1976 |
| Mr. Michael R. Deperro | Senior VP & Head of Operations | — |
| Dr. Davelyn Eaves Hood M.B.A., M.D. | Director and Head of Scientific & Patient Affairs | — |
| Ms. Melissa Quinn | Senior Director of People and Culture | — |
| Mr. Michael Covarrubias | Senior VP & Head of Program & Portfolio Management | — |
| Mr. Chris Milks | VP & Head of Finance | — |
| Dr. Raj Agrawal M.D. | VP & Head of Ophthalmological Clinical Development | — |
| Ms. Robyn Sweinhart | VP & Head of Quality | — |
Fundamentals
Valuation
Market cap$369.76M
Price-to-sales ratioN/A
Price-to-book value3.17
Price-earnings ratio-4.50
Return on Equity-59.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.82
Income Statement
Average volume1,573,030
EBITDA$-80.89M
1 year high (52w)$11.46
1 year low (52w)$1.07
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



